Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)
HKD 1.39
(-0.71%)
HKD 1.39
(-0.71%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 72 Million CNY | 0.0% |
| 2022 | - CNY | 0.0% |
| 2021 | - CNY | 0.0% |
| 2020 | - CNY | -100.0% |
| 2019 | 490 Thousand CNY | -55.86% |
| 2018 | 1.11 Million CNY | -32.19% |
| 2017 | 1.63 Million CNY | -27.98% |
| 2016 | 2.27 Million CNY | -21.84% |
| 2015 | 2.9 Million CNY | -61.29% |
| 2014 | 7.51 Million CNY | -7.79% |
| 2013 | 8.14 Million CNY | 70.32% |
| 2012 | 4.78 Million CNY | -11.72% |
| 2011 | 5.41 Million CNY | -10.49% |
| 2010 | 6.05 Million CNY | -13.39% |
| 2009 | 6.99 Million CNY | 0.0% |
| 2008 | 6.99 Million CNY | 7.14% |
| 2007 | 6.52 Million CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| 2004 | - CNY | 0.0% |
| 2003 | - CNY | 0.0% |
| 2002 | - CNY | 0.0% |
| 2001 | - CNY | 0.0% |
| 2000 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 75.35 Million CNY | 4.65% |
| 2024 Q2 | 75.35 Million CNY | 0.0% |
| 2023 Q2 | 2.37 Million CNY | 0.0% |
| 2023 Q3 | - CNY | -100.0% |
| 2023 Q1 | - CNY | 0.0% |
| 2023 FY | 72 Million CNY | 0.0% |
| 2023 Q4 | 72 Million CNY | 0.0% |
| 2022 FY | - CNY | 0.0% |
| 2022 Q4 | - CNY | 0.0% |
| 2022 Q3 | - CNY | -100.0% |
| 2022 Q1 | - CNY | 0.0% |
| 2022 Q2 | 1.41 Million CNY | 0.0% |
| 2021 FY | - CNY | 0.0% |
| 2021 Q2 | - CNY | 0.0% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 Q4 | - CNY | 0.0% |
| 2020 FY | - CNY | -100.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2019 Q4 | 490 Thousand CNY | 0.0% |
| 2019 Q2 | 1.11 Million CNY | 0.0% |
| 2019 FY | 490 Thousand CNY | -55.86% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 Q4 | 1.11 Million CNY | 0.0% |
| 2018 Q2 | 1.09 Million CNY | 0.0% |
| 2018 FY | 1.11 Million CNY | -32.19% |
| 2017 Q2 | 2.27 Million CNY | 0.0% |
| 2017 Q4 | 1.63 Million CNY | 0.0% |
| 2017 FY | 1.63 Million CNY | -27.98% |
| 2017 Q1 | - CNY | -100.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 FY | 2.27 Million CNY | -21.84% |
| 2016 Q4 | 2.27 Million CNY | 0.0% |
| 2016 Q2 | 2.9 Million CNY | 0.0% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 Q2 | 7.51 Million CNY | 0.0% |
| 2015 Q4 | 2.9 Million CNY | 0.0% |
| 2015 FY | 2.9 Million CNY | -61.29% |
| 2014 Q4 | 7.51 Million CNY | 0.0% |
| 2014 FY | 7.51 Million CNY | -7.79% |
| 2014 Q2 | 8.14 Million CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2013 Q1 | - CNY | -100.0% |
| 2013 Q4 | 8.14 Million CNY | 0.0% |
| 2013 Q2 | 9.45 Million CNY | 0.0% |
| 2013 FY | 8.14 Million CNY | 70.32% |
| 2012 Q4 | 4.78 Million CNY | 0.0% |
| 2012 Q2 | 5.41 Million CNY | 0.0% |
| 2012 FY | 4.78 Million CNY | -11.72% |
| 2011 Q4 | 5.41 Million CNY | 0.0% |
| 2011 FY | 5.41 Million CNY | -10.49% |
| 2011 Q2 | 6.69 Million CNY | 0.0% |
| 2010 Q4 | 6.05 Million CNY | 0.0% |
| 2010 Q2 | 6.99 Million CNY | 0.0% |
| 2010 FY | 6.05 Million CNY | -13.39% |
| 2009 FY | 6.99 Million CNY | 0.0% |
| 2008 FY | 6.99 Million CNY | 7.14% |
| 2007 FY | 6.52 Million CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |
| 2004 FY | - CNY | 0.0% |
| 2003 FY | - CNY | 0.0% |
| 2002 FY | - CNY | 0.0% |
| 2001 FY | - CNY | 0.0% |
| 2000 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 2.07 Million HKD | -3373.229% |
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | 92.727% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | 38.527% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | 73.932% |
| Qianhai Health Holdings Limited | - HKD | -Infinity% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | -1.931% |
| Essex Bio-Technology Limited | 36.05 Million HKD | -99.685% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | -462.456% |
| PuraPharm Corporation Limited | 81.09 Million HKD | 11.213% |
| SSY Group Limited | 1.94 Billion HKD | 96.303% |
| JBM (Healthcare) Limited | 43.8 Million HKD | -64.384% |
| Jacobson Pharma Corporation Limited | 592.2 Million HKD | 87.842% |
| China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 99.567% |